18th Nov 2021 13:13
18 November 2021
NANOCO GROUP PLC
("Nanoco", the "Group" or the "Company")
DIRECTOR/PDMR SHAREHOLDING
Nanoco (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other specific nanomaterials emanating from our technology platform, has been notified that Dr Christopher Richards, Non-Executive Chairman, sold in aggregate 174,999 ordinary shares of 10p each in the Company ("Ordinary Shares") and subsequently purchased 174,999 ordinary shares of 10p each held in funds in the name of his wife, Ann Carolyn Richards.
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation,
Notification of Dealing Form
1. | Details of the Person Discharging Managerial Responsibilities ("PDMR") / person closely associated with them ("PCA") | |||||
a) | Name | CHRISTOPHER RICHARDS | ||||
2. | Reason for the notification | |||||
a) | Position /status | NON-EXECUTIVE CHAIRMAN | ||||
b) | Initial notification / amendment | INITIAL NOTIFICATION | ||||
3. | Details of the Issuer | |||||
a) | Name | NANOCO GROUP PLC | ||||
b) | LEI code | 213800HOSJEZO1KOCV33 | ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Type of instrumentIdentification code | ORDINARY SHARES OF 1O PENCE EACH | ||||
ISIN: GB00B01JLR99 | ||||||
b) | Nature of the transaction | SALE OF ORDINARY SHARES | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information:- Aggregated volume- Price |
| ||||
e) | Date of the transaction | 17 NOVEMBER 2021 | ||||
f) | Place of the transaction | LONDON STOCK EXCHANGE |
Notification of Dealing Form
1. | Details of the Person Discharging Managerial Responsibilities ("PDMR") / person closely associated with them ("PCA") | |||||
a) | Name | ANN RICHARDS | ||||
2. | Reason for the notification | |||||
a) | Position /status | CONNECTED PERSON TO CHRISTOPHER RICHARDS, NON-EXECUTIVE CHAIRMAN | ||||
b) | Initial notification / amendment | INITIAL NOTIFICATION | ||||
3. | Details of the Issuer | |||||
a) | Name | NANOCO GROUP PLC | ||||
b) | LEI code | 213800HOSJEZO1KOCV33 | ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Type of instrumentIdentification code | ORDINARY SHARES OF 1O PENCE EACH | ||||
ISIN: GB00B01JLR99 | ||||||
b) | Nature of the transaction | PURCHASE OF ORDINARY SHARES | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information:- Aggregated volume- Price |
| ||||
e) | Date of the transaction | 17 NOVEMBER 2021 | ||||
f) | Place of the transaction | LONDON STOCK EXCHANGE |
For further information please contact:
Liam GrayCompany SecretaryTelephone : +44 (0) 161 603 7900
Notes for editors:
About Nanoco Group plc
Nanoco (LSE: NANO) harnesses the power of nano-materials. Nano-materials are materials with dimensions typically in the range 1 - 100 nm. Nano-materials have a range of useful properties, including optical and electronic. Quantum dots are a subclass of nano-material that have size-dependent optical and electronic properties. The Group produces quantum dots. Within the sphere of quantum dots, the Group exploits different characteristics of the quantum dots to target different performance criteria that are attractive to specific markets or end-user applications such as the Display and Electronics markets. One of the interesting properties of quantum dots is photoluminescence: the emission of longer wavelength light upon excitation by light of a shorter wavelength. The colour of light emitted depends on the particle size. Nanoco's CFQD® quantum dots are free of cadmium and other toxic heavy metals and can be tuned to emit light at different wavelengths across the visible and infrared spectrum, rendering them useful for a wide range of applications including displays, lighting and biological imaging.
Nanoco was founded in 2001 and is headquartered in Manchester, UK, with a US subsidiary, Nanoco Inc., in Concord, MA. Nanoco continues to build out a world-class, patent-protected IP portfolio generated both by its own innovation engine, as well as through acquisition.
Nanoco is listed on the Main Market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocotechnologies.com.
= END =
Related Shares:
Nanoco